The 20 Best Immune Thrombocytopenic Purpura (ITP) Doctors Near Me in District of Columbia, US

James Taylor is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Taylor is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobin SC Disease, Thalassemia, and Hemoglobin E Disease. Dr. Taylor is board certified in Pediatric Hematology-Oncology. Dr. Taylor is currently accepting new patients.

Craig Kessler is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Kessler is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Blood Clots, Hemophilia A, Acquired Hemophilia, Bone Marrow Aspiration, and Splenectomy.

Catherine Broome is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Broome is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Autoimmune Hemolytic Anemia, Chronic B-Cell Leukemia (CBCL), Immune Thrombocytopenic Purpura (ITP), Bone Marrow Aspiration, and Splenectomy.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 61 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, and Chronic Lymphocytic Leukemia (CLL). Dr. Kressel is board certified in American Board Of Internal Medicine.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy. Dr. Boudadi is board certified in American Board Of Internal Medicine.

Haroon Shaukat is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 13 years. Dr. Shaukat is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His clinical expertise encompasses Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Immune Thrombocytopenic Purpura (ITP), Asthma in Children, Autism Spectrum Disorder, and Gallbladder Removal. Dr. Shaukat is board certified in American Board Of Pediatrics, 2021 and American Board Of Pediatrics, 2017.

Michael F. Guerrera, MD, is the director of the Comprehensive Hemostasis and Thrombosis Program in the Division of Hematology. He served on the Region III Executive Committee for eight years. His clinical interest is in bleeding disorders and general hematology. Dr. Guerrera also has an interest in medical education, was a director of the Hematology Oncology Fellowship Program for eight years and was a participant in the first Children's National Hospital and the George Washington University Master Teacher Program. Dr. Guerrera is the recipient of the 2018 National Hemophilia Foundation Physician of the Year Award. Dr. Guerrera is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Hemophilia A, Blood Clots, Hemophilia B, and Hemophilic Arthropathy. Dr. Guerrera is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2002 and Pediatrics: American Board Of Pediatrics, 1998.

Julia Cunningham is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Cunningham is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Thrombocytopenia, Essential Thrombocythemia, Adult Immune Thrombocytopenia, Pulmonary Embolism, and Bone Marrow Aspiration.

Suvankar Majumdar, MD, is chief of the Division of Hematology at Children’s National. Dr. Majumdar completed his medical training from the University of Zimbabwe College of Health Sciences and pediatric residency from Michigan State University. He previously served as the director of the Comprehensive Pediatric Sickle Cell Program at the University of Mississippi Medical Center, and also directed the Hemophilia Treatment Center. He is a recognized leader in hematology and sickle cell disease, and is passionate about taking care of patients and families living with hematological disorders. In addition to his broad clinical expertise, Dr. Majumdar is an accomplished researcher and a principal investigator of NIH-funded studies. He is currently evaluating a novel drug for treating sickle cell pain and investigating specific genetic mutations that might be associated with irregular heartbeats in this high-risk population. Dr. Majumdar is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Majumdar is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009.

Yaser Diab, MD, is a hematologist at Children's National. He specializes in Kaposiform Hemangioendothelioma with Kasabach-Merritt Syndrome. Dr. Diab is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses May Thurner Syndrome, Mesenteric Venous Thrombosis, Sickle Cell Disease, and Venous Thromboembolism (VTE). Dr. Diab is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2013.

Robert Nickel is a Hematologist and a Pediatrics provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 18 years. Dr. Nickel is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Nickel is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2015, Blood Banking/Transfusion Medicine: American Board Of Pathology, 2015, and Pediatrics: American Board Of Pediatrics, 2011.

Edward Wong is an Allergy and Immunologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 37 years. Dr. Wong is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His clinical expertise encompasses Hemolytic Transfusion Reaction, Anemia, Hemolysis, and Blood Clots. Dr. Wong is board certified in Blood Banking/Transfusion Medicine: American Board Of Pathology, 2004 and American Board Of Pathology, 1994.

Upendra Mahat is a Pediatrics specialist and a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 18 years. Dr. Mahat is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His clinical expertise encompasses Classical Hodgkin Lymphoma, Infantile Neutropenia, Atypical Hemolytic Uremic Syndrome (aHUS), and Immune Thrombocytopenic Purpura (ITP). Dr. Mahat is board certified in American Board Of Pediatrics, 2023 and Pediatrics: American Board Of Pediatrics, 2020.

Andrew Campbell, MD, began his distinguished training and career path at Morehouse College. He continued medical school at Case Western Reserve University and completed post graduate training at Massachusetts General Hospital (Harvard) and Lurie Children's Hospital (Northwestern University). Prior to joining Children’s National, Dr. Campbell was Director of the Comprehensive Sickle Cell Center at the University of Michigan, a position he held since 2005. His research interests span several topics in sickle cell disease including pulmonary complications, fetal hemoglobin switching in transgenic sickle cell mice, phenotype/genotype relationships and renal complications. Dr. Campbell is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobin SC Disease, Alpha Thalassemia, and Hemolytic Anemia. Dr. Campbell is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2004.

Hyojeong Han is a Transfusion Medicine specialist and a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 13 years. Dr. Han is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Anemia, and Hemolytic Anemia. Dr. Han is board certified in American Board Of Pathology, 2021, American Board Of Pediatrics, 2021, and American Board Of Pediatrics, 2016.

Thomas Newton is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 30 years. Dr. Newton is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Sickle Cell Disease, Febrile Neutropenia, and Hemolysis. Dr. Newton is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 1999.

Adriana Sheridan is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 20 years. Dr. Sheridan is rated as undefined provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, Pediatric Low-Grade Glioma (pLGG), and Glioma. Dr. Sheridan is board certified in Pediatrics: American Board Of Pediatrics, 2024, Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021, and The Royal College Of Physicians And Surgeons Of Canada, 2015.

Nita L. Seibel, MD, is a board-certified pediatrician and pediatric hematologist-oncologist. After graduating from the Ohio State University College of Medicine in 1988, she completed her internship and residency at the Ohio State University Children’s Hospital in 1984. Dr. Seibel completed a fellowship in pediatric hematology-oncology at the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health in 1987. She joined the faculty of Children's National Hospital in 1988 and is a professor of pediatrics at the George Washington University School of Medicine & Health Sciences. While at Children's National, Dr. Seibel has served for over 15 years on the Institutional Review Board, as Director of the Hematology/Oncology Training Program for nine years and as Principal Investigator for Children's Oncology Group. Dr. Seibel has chaired numerous studies for the Children’s Oncology Group including chairing the Phase I Data Safety Monitoring Committee and served as vice-chair for Phase I agents. Dr. Seibel was also a member of the National Wilms Tumor Study and later the COG Renal Tumor Committee. Dr. Seibel's areas of special interest are: Wilms tumor, bone tumors, ALL, and adolescent and young adult oncology as well as late effects. She also has a special interest in Acute Lymphoblastic Leukemia in adolescents and young adults and anti-fungal agents. Dr. Seibel is rated as undefined provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult Soft Tissue Sarcoma, and Infantile Neutropenia. Dr. Seibel is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1987 and Pediatrics: American Board Of Pediatrics, 1986.

Brian R. Rood, MD, is the director of clinical neuro-oncology and the medical director of the Brain Tumor Institute at Children's National Hospital. Dr. Rood is also a principal investigator in the Center for Cancer and Immunology Research at Children's National Research Institute and a professor of pediatrics at the George Washington University School of Medicine and Health Sciences and adjunct professor at the Fralin Biomedical Research Institute at Virginia Tech. He received a Bachelor of Arts in English Literature from The Pennsylvania State University and completed medical school at Jefferson Medical College. He completed his pediatric residency training at the University of Vermont. Dr. Rood received his pediatric hematology/oncology training at Children's National. He joined the faculty of Children’s National in 2002 after completing a fellowship in pediatric hematology/oncology, as well as a research fellowship in the molecular biology of brain tumors, both at Children’s National and Children’s National Research Institute. Currently, Dr. Rood’s research focuses on the application of proteomics in cancer biology investigation, neoantigen identification and biomarker development. He has also been studying the contribution of germline microsatellite genotypes to pediatric brain tumor predisposition. He currently serves as the executive co-chair of the Children’s Brain Tumor Network, an international consortium of 28 institutions that maintains the world’s largest pediatric brain tumor tissue and data repository, which are freely provided to the research community to support the development of groundbreaking clinical trials through data-driven precision medicine. Dr. Rood has two children. His favorite pastimes include designing and building furniture, sailing, reading, and playing the mandolin. Dr. Rood is rated as undefined provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Diffuse Midline Glioma H3 K27M-Mutant. Dr. Rood is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2002 and Pediatrics: American Board Of Pediatrics, 1998.